Together, our results reveal a previously unknown mechanism by which FTY720 functions in multiple sclerosis, and suggests that targeting TCF-1 signaling in CD4+ T cells could be a potential treatment strategy for multiple sclerosis. This evidence concerns the gene TCF7 and multiple sclerosis.